Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Safety & Efficacy of Zirconium Silicate Dosed for 28 Days in Hyperkalemia.

ClinicalTrials.gov ID: NCT02088073

Public ClinicalTrials.gov record NCT02088073. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 6:06 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Multicenter, Multi-phase, Multi-dose, Prospective, Double-blind, Placebo-controlled, Maintenance Study of Safety and Efficacy of ZS (Microporous, Fractionated, Protonated Zirconium Silicate) in Hyperkalemia.

Study identification

NCT ID
NCT02088073
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
ZS Pharma, Inc.
Industry
Enrollment
258 participants

Conditions and interventions

Conditions

Interventions

  • Sodium zirconium cyclosilicate Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 30, 2014
Primary completion
Aug 30, 2014
Completion
Jan 30, 2015
Last update posted
Dec 6, 2018

2014 – 2015

United States locations

U.S. sites
38
U.S. states
17
U.S. cities
38
Facility City State ZIP Site status
Not listed Anniston Alabama
Not listed Huntsville Alabama
Not listed Scottsboro Alabama
Not listed Phoenix Arizona
Not listed Tempe Arizona
Not listed Hawaiian Gardens California
Not listed Los Angeles California
Not listed Paramount California
Not listed Riverside California
Not listed Atlantis Florida
Not listed Bradenton Florida
Not listed Brandon Florida
Not listed Brooksville Florida
Not listed DeLand Florida
Not listed Edgewater Florida
Not listed Miami Florida
Not listed Miami Lakes Florida
Not listed New Smyrna Beach Florida
Not listed Ocala Florida
Not listed Summerfield Florida
Not listed Tampa Florida
Not listed Winter Park Florida
Not listed Columbus Georgia
Not listed Decatur Georgia
Not listed Evergreen Park Illinois
Not listed Joliet Illinois
Not listed Shreveport Louisiana
Not listed Auburn Maine
Not listed Chesterfield Michigan
Not listed Kansas City Missouri
Not listed Las Vegas Nevada
Not listed Flushing New York
Not listed Altoona Pennsylvania
Not listed Providence Rhode Island
Not listed Orangeburg South Carolina
Not listed Sumter South Carolina
Not listed Chattanooga Tennessee
Not listed San Antonio Texas

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 8 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02088073, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 6, 2018 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02088073 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →